To test the effects of BAP1 inhibition on SCLC progression in vivo, we established a mouse xenograft model by inoculating mouse KP3 SCLC (p53/Rb mutant) cells into the right flank of athymic nude mice. The gene discussed is RB1; the disease is small cell lung carcinoma.